The Futurum Group CEO Daniel Newman said Hims is the “most likely public company play†for peptides at scale.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Hims & Hers Finds A GLP-1 Hedge? HIMS Stock Rallies As RFK Jr. Signals Peptide Clearances
The Futurum Group CEO Daniel Newman said Hims is the “most likely public company play†for peptides at scale.